Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

InnoCare Pharma has announced that its Phase II clinical study of the Tyrosine Kinase 2 (TYK2) inhibitor ICP-488 for ...

InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

Psoriasis is a multifactorial immune-mediated inflammatory disease. Its pathogenesis involves abnormal accumulation of neutrophils and T-cell related abnormalities. Pyroptosis is a type of regulated ...

those with psoriasis that’s not well-controlled, those who have undergone multiple treatments, and people who are stressed out. The Koebner phenomenon is more likely to happen in colder weather ...

Those most likely to benefit from such a treatment are patients with pustular psoriasis (PP)—a particularly severe and treatment-resistant form of the disease that can affect a patient's nails ...

Those most likely to benefit from such a treatment are patients with pustular psoriasis (PP) – a particularly severe and treatment-resistant form of the disease that can affect a patient's nails ...

"Recognizing how stress influences psoriasis allows us to refine our treatment approaches to better serve patients," Professor Gilhar adds. "Looking ahead, our team plans to explore the clinical ...